Skip to main content
. 2021 Oct 26;12:767982. doi: 10.3389/fphar.2021.767982

TABLE 4.

Incidence of cardiovascular diseases in study patients.

All OS group COPD group OSAS group p value p value OS and COPD p value OS and OSAS
n = 395 n = 79 n = 158 n = 158
CHD, n (%) 97 (24.6) 24 (30.4) 15 (9.5) 58 (36.7) <0.001 <0.001 0.334
Arrhythmia, n (%) 58 (14.7) 18 (22.8) 19 (12.0) 21 (13.3) 0.072 0.031 0.063
 Conduction block, n (%) 13 (3.3) 5 (6.3) 4 (2.5) 4 (2.5) 0.296 0.280 0.280
 Ventricular arrhythmias, n (%) 9 (2.3) 2 (2.5) 4 (2.5) 9 (2.3) 1.000 1.000 1.000
 Atrial arrhythmia, n (%) 36 (9.1) 11 (13.9) 11 (7.0) 14 (8.9) 0.212 0.082 0.232
 AF, n (%) 27 (6.8) 11 (13.9) 7 (4.4) 9 (6.8) 0.018 0.009 0.032
Heart failure, n (%) 43 (10.9) 28 (35.4) 14 (8.9) 1 (0.6) <0.001 <0.001 <0.001
Stroke, n (%) 70 (17.7) 15 (19.0) 21 (13.3) 34 (21.5) 0.151 0.249 0.650
PH, n (%) 64 (16.2) 29 (36.71) 28 (17.1) 7 (4.4) <0.001 0.001 <0.001
 Mild 33 (51.6) 14 (48.3) 15 (53.6) 4 (57.1)
 Moderate 20 (31.2) 11 (37.9) 7 (25.0) 2 (28.6)
 Severe 11 (17.2) 4 (13.8) 6 (21.4) 1 (14.3)

CHD, coronary heart disease; AF, atrial fibrillation; PH, pulmonary hypertension; other abbreviations as in Table 1.